Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin and calciferol for lower urinary tract symptoms in benign prostatic hyperplasia
IRCT20200906048641N1Phase 2Completed
- Sponsor
- Islamic Azad University
- Start
- Dec 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of silymarin and vitamin d in benign prostatic hyperplasia (BPH) and Micturition disorder, sponsored by Islamic Azad University. Started Dec 2019; status: completed.
02
Drugs
silymarinvitamin d
03
Conditions
benign prostatic hyperplasia (BPH)Micturition disorder
Beyond the preview
Go deeper on IRCT20200906048641N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200906048641N1.